Top compounds associated with response to TBC1D3


Feature Type Standardized
Nominal ANOVA
mRNA istradefylline CTRPv2 pan-cancer AAC -0.006 0.9
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0038 0.9
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC -0.0043 0.9
mRNA BRD8958 CTRPv2 pan-cancer AAC 0.0041 0.9
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0036 0.9
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.0039 0.9
mRNA skepinone-L CTRPv2 pan-cancer AAC -0.0049 0.9
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.0035 0.9
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.0034 0.9
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0032 0.9
Download CSV